All filters
Slidesets
Real-life experiences - bottlenecks & hurdles- Australia- Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Slidesets
Real-life experiences - bottlenecks & hurdles- Nigeria, sub-Saharan Africa- Olufunmilayo Lesi, MD, MBA, FMCP, FWACP
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Slidesets
Prevention transmission strategies prior to infection - People who inject drugs- Diana Sylvestre, MD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Slidesets
Prevention transmission strategies prior to infection - Incarceration- Lara Strick, MD, MS
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Slidesets
Prevention transmission strategies through strengthening the health system- Maia Butshashvili, MD, MS, PhD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Slidesets
Micro-elimination as a strategy to reach global elimination- Jeffrey Lazarus, PhD, MIH, MA
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Slidesets
Medicines Patent Pool’s approach to scale up access to HIV and HCV treatment- Esteban Burrone
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2017
Slidesets
TAF – The latest update, which questions remain to be answered?- Pietro Lampertico, MD, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Hepatitis B Cure: From Discovery to Regulatory Endpoints in HBV clinical research: A summary of the AASLD/EASL statement- Fabien Zoulim, MD, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
How does HBV interact with the immune system- Mala Maini, MD, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Is immunomodulation really needed to cure HBV?- Harry Janssen, MD, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Innate Immunity : TLR, RIG-I, STING and potential others- Adam Gehring, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Adaptive Immunity: Therapeutic vaccination, checkpoint inhibition and potential others- Andre Boonstra, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Entry inhibition- Stephan Urban, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
CCC – DNA inhibition- Anuj Gaggar, MD, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
RNA interference- Bill Symonds, PharmD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Other virological mechanisms- Stephen Locarnini, BSc, PhD, MBBS, FRCP
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Innovative trial design- Henry Lik Yuen Chan
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Combination therapy how to navigate in a minefield of efficacy and toxicity?- Jordan Feld, MD, MPH
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Hepatitis E in HIV- Kenneth Sherman, MD, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
News on hepatitis delta and HIV infections- Vincent Soriano, MD, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
Management of HCV in intravenous drug users: special considerations- Rui Sarmento e Castro, MD, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017